Wildflower Brands Inc. Share Price Canadian Securities Exchange
Equities
SUN
CA96812N1050
Pharmaceuticals
Sales 2018 | 1.41 1.93 117.48 | Sales 2019 | 7.09 9.7 591.12 | Capitalization | 63.9M 87.44M 5.33B |
---|---|---|---|---|---|
Net income 2018 | -7M -9.58M -584M | Net income 2019 | -4M -5.47M -334M | EV / Sales 2018 | 4,49,08,398 x |
Net Debt 2018 | 7.85M 10.75M 655M | Net Debt 2019 | 7.32M 10.01M 610M | EV / Sales 2019 | 1,00,51,719 x |
P/E ratio 2018 |
-6.99
x | P/E ratio 2019 |
-6.61
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 18/14/18 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/13/30 |
Myron van Snick
COO | Chief Operating Officer | - | 13/20/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/13/30 |
William MacLean
CEO | Chief Executive Officer | - | 18/14/18 |
Director/Board Member | - | 06/18/06 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |